Literature DB >> 19767452

Monoacylglycerol lipase limits the duration of endocannabinoid-mediated depolarization-induced suppression of excitation in autaptic hippocampal neurons.

Alex Straiker1, Sherry Shu-Jung Hu, Jonathan Z Long, Andy Arnold, Jim Wager-Miller, Benjamin F Cravatt, Ken Mackie.   

Abstract

Depolarization-induced suppression of excitation (DSE) is a major form of cannabinoid-mediated short-term retrograde neuronal plasticity and is found in numerous brain regions. Autaptically cultured murine hippocampal neurons are an architecturally simple model for the study of cannabinoid signaling, including DSE. The transient nature of DSE--tens of seconds--is probably determined by the regulated hydrolysis of the endocannabinoid 2-arachidonoyl glycerol (2-AG). No less than five candidate enzymes have been considered to serve this role: fatty acid amide hydrolase (FAAH), cyclooxygenase-2 (COX-2), monoacylglycerol lipase (MGL), and alpha/beta-hydrolase domain (ABHD) 6 and 12. We previously found that FAAH and COX-2 do not have a role in determining the duration of autaptic DSE. In the current study, we found that two structurally distinct inhibitors of MGL [N-arachidonoyl maleimide and 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184)] prolong DSE in autaptic hippocampal neurons, whereas inhibition of ABHD6 by N-methyl-N-[[3-(4-pyridinyl)phenyl]methyl]-4'-(aminocarbonyl)[1,1'-biphenyl]-4-yl ester, carbamic acid (WWL70) had no effect. In addition, we developed antibodies against MGL and ABHD6 and determined their expression in autaptic cultures. MGL is chiefly expressed at presynaptic terminals, optimally positioned to break down 2-AG that has engaged presynaptic CB(1) receptors. ABHD6 is expressed in two distinct locations on autaptic islands, including a prominent localization in some dendrites. In summary, we provide strong pharmacological and anatomical evidence that MGL regulates DSE in autaptic hippocampal neurons and, taken together with other studies, emphasizes that endocannabinoid signaling is terminated in temporally diverse ways.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19767452      PMCID: PMC2784730          DOI: 10.1124/mol.109.059030

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  47 in total

1.  Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells.

Authors:  A C Kreitzer; W G Regehr
Journal:  Neuron       Date:  2001-03       Impact factor: 17.173

2.  Cerebellar depolarization-induced suppression of inhibition is mediated by endogenous cannabinoids.

Authors:  A C Kreitzer; W G Regehr
Journal:  J Neurosci       Date:  2001-10-15       Impact factor: 6.167

3.  Endocannabinoids mediate rapid retrograde signaling at interneuron right-arrow pyramidal neuron synapses of the neocortex.

Authors:  Joseph Trettel; Eric S Levine
Journal:  J Neurophysiol       Date:  2003-04       Impact factor: 2.714

4.  Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2.

Authors:  K R Kozak; S W Rowlinson; L J Marnett
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

5.  Excitatory and inhibitory autaptic currents in isolated hippocampal neurons maintained in cell culture.

Authors:  J M Bekkers; C F Stevens
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

6.  Role of the basolateral nucleus of the amygdala in endocannabinoid-mediated stress-induced analgesia.

Authors:  Katherine Connell; Nathan Bolton; Daniel Olsen; Daniele Piomelli; Andrea G Hohmann
Journal:  Neurosci Lett       Date:  2005-12-27       Impact factor: 3.046

7.  Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals.

Authors:  T Ohno-Shosaku; T Maejima; M Kano
Journal:  Neuron       Date:  2001-03       Impact factor: 17.173

8.  Presynaptic specificity of endocannabinoid signaling in the hippocampus.

Authors:  R I Wilson; G Kunos; R A Nicoll
Journal:  Neuron       Date:  2001-08-16       Impact factor: 17.173

9.  Brain monoglyceride lipase participating in endocannabinoid inactivation.

Authors:  T P Dinh; D Carpenter; F M Leslie; T F Freund; I Katona; S L Sensi; S Kathuria; D Piomelli
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-22       Impact factor: 11.205

10.  Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain.

Authors:  Tiziana Bisogno; Fiona Howell; Gareth Williams; Alberto Minassi; Maria Grazia Cascio; Alessia Ligresti; Isabel Matias; Aniello Schiano-Moriello; Praveen Paul; Emma-Jane Williams; Uma Gangadharan; Carl Hobbs; Vincenzo Di Marzo; Patrick Doherty
Journal:  J Cell Biol       Date:  2003-11-10       Impact factor: 10.539

View more
  60 in total

1.  Role of neuronal nitric oxide synthase in the estrogenic attenuation of cannabinoid-induced changes in energy homeostasis.

Authors:  Amanda Borgquist; Cecilia Meza; Edward J Wagner
Journal:  J Neurophysiol       Date:  2014-11-12       Impact factor: 2.714

2.  Monoacylglycerol lipase: stopping surplus at the synapse.

Authors:  Jaclyn I Wamsteeker; Jaideep S Bains
Journal:  J Physiol       Date:  2011-11-15       Impact factor: 5.182

3.  Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight.

Authors:  Vincenzo Di Marzo
Journal:  Nat Neurosci       Date:  2011-01       Impact factor: 24.884

Review 4.  Functional Relevance of Endocannabinoid-Dependent Synaptic Plasticity in the Central Nervous System.

Authors:  Shana M Augustin; David M Lovinger
Journal:  ACS Chem Neurosci       Date:  2018-02-19       Impact factor: 4.418

Review 5.  Endocannabinoid-mediated synaptic plasticity and addiction-related behavior.

Authors:  Nimish Sidhpura; Loren H Parsons
Journal:  Neuropharmacology       Date:  2011-06-12       Impact factor: 5.250

6.  An animal model of female adolescent cannabinoid exposure elicits a long-lasting deficit in presynaptic long-term plasticity.

Authors:  Jonathan W Lovelace; Alex Corches; Philip A Vieira; Alex S Hiroto; Ken Mackie; Edward Korzus
Journal:  Neuropharmacology       Date:  2015-05-13       Impact factor: 5.250

Review 7.  Therapeutic potential of monoacylglycerol lipase inhibitors.

Authors:  Melinda M Mulvihill; Daniel K Nomura
Journal:  Life Sci       Date:  2012-11-08       Impact factor: 5.037

8.  Alterations in the hippocampal endocannabinoid system in diet-induced obese mice.

Authors:  Federico Massa; Giacomo Mancini; Helmut Schmidt; Frauke Steindel; Ken Mackie; Carlo Angioni; Stéphane H R Oliet; Gerd Geisslinger; Beat Lutz
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

Review 9.  Endocannabinoids in synaptic plasticity and neuroprotection.

Authors:  Jian-Yi Xu; Chu Chen
Journal:  Neuroscientist       Date:  2014-02-25       Impact factor: 7.519

10.  Selective inhibition of alpha/beta-hydrolase domain 6 attenuates neurodegeneration, alleviates blood brain barrier breakdown, and improves functional recovery in a mouse model of traumatic brain injury.

Authors:  Flaubert Tchantchou; Yumin Zhang
Journal:  J Neurotrauma       Date:  2013-04-05       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.